Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Ferritin Test Enables Iron Deficiency Detection at the Point of Care

By LabMedica International staff writers
Posted on 22 Aug 2026

Iron deficiency is one of the world’s most common nutritional disorders and can be difficult to diagnose where access to laboratories and trained personnel is limited. More...

Women and children in low-resource settings are particularly affected, and delayed detection can worsen maternal anemia and newborn outcomes. Because hemoglobin screening alone may miss iron deficiency before anemia develops, earlier biomarker testing is needed. Researchers have now introduced a rapid, point-of-care ferritin test designed to expand timely diagnosis and treatment.

Walter and Eliza Hall Institute of Medical Research (WEHI) has developed a 15-minute, finger-prick point-of-care (POC) ferritin test intended to deliver accurate results in a single visit. The assay is designed to be used without specialized laboratory equipment and can be administered by a broad range of health care professionals, minimizing the need for dedicated training. WEHI states the device provides a clear visual reference at the clinically important ferritin threshold of 30 ng/mL to help clinicians identify iron deficiency at the POC.

The test measures ferritin, described as the gold‑standard biomarker for iron deficiency, allowing detection before anemia develops. According to WEHI, accuracy closely matches standard laboratory ferritin measurements, reducing the need for a follow‑up venous blood draw and facilitating both diagnosis and ongoing monitoring. While other rapid ferritin tests exist, the stated threshold-based visual readout is intended to support confident decision‑making in under‑resourced settings.

Field validation and implementation are planned in Malawi and Kenya following contract manufacturing under relevant international industry standards. The deployment aims to demonstrate real‑world performance, generate critical evidence, and establish a pathway for rapid implementation in low‑resource settings. In 2025, a WEHI‑led trial with the Training Research Unit of Excellence (Malawi) found that a single iron infusion in the third trimester significantly reduced iron‑deficient anemia in pregnant women; the new test is intended to help identify who would benefit most from such treatment. Completion of the current project is expected to advance the test toward regulatory approval and global distribution.

“Iron infusions are among the most prescribed medicines in Australia—reflecting the prevalence of iron deficiency and availability of effective treatment options. But simple methods to diagnose the condition remain largely out of reach for those living outside of high-income countries. Our test could close this health inequity gap and transform the lives of millions of women and babies around the world,” said Emily Eriksson, who co-led the research team that developed the test at the Walter and Eliza Hall Institute of Medical Research.

“Identifying iron deficiency in the context of, or even before it progresses to anemia, is the critical gap this test is addressing. Too often, women with low iron stores are missed because their hemoglobin levels appear normal. By directly identifying low ferritin levels, our test enables clinicians to clearly identify those women who are truly iron deficient and would benefit from timely treatment,” said Ricardo Ataide, who will lead the field validation and implementation of the diagnostic at the Walter and Eliza Hall Institute of Medical Research.

Related Links
Walter and Eliza Hall Institute of Medical Research


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.